1. Home
  2. CVRX vs EVGO Comparison

CVRX vs EVGO Comparison

Compare CVRX & EVGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVRX
  • EVGO
  • Stock Information
  • Founded
  • CVRX 2000
  • EVGO 2010
  • Country
  • CVRX United States
  • EVGO United States
  • Employees
  • CVRX N/A
  • EVGO N/A
  • Industry
  • CVRX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • EVGO Other Specialty Stores
  • Sector
  • CVRX Health Care
  • EVGO Consumer Discretionary
  • Exchange
  • CVRX Nasdaq
  • EVGO Nasdaq
  • Market Cap
  • CVRX 419.8M
  • EVGO 372.5M
  • IPO Year
  • CVRX 2021
  • EVGO N/A
  • Fundamental
  • Price
  • CVRX $13.85
  • EVGO $2.91
  • Analyst Decision
  • CVRX Strong Buy
  • EVGO Strong Buy
  • Analyst Count
  • CVRX 7
  • EVGO 10
  • Target Price
  • CVRX $17.83
  • EVGO $6.11
  • AVG Volume (30 Days)
  • CVRX 219.8K
  • EVGO 4.1M
  • Earning Date
  • CVRX 02-04-2025
  • EVGO 03-05-2025
  • Dividend Yield
  • CVRX N/A
  • EVGO N/A
  • EPS Growth
  • CVRX N/A
  • EVGO N/A
  • EPS
  • CVRX N/A
  • EVGO N/A
  • Revenue
  • CVRX $51,292,000.00
  • EVGO $239,306,000.00
  • Revenue This Year
  • CVRX $27.21
  • EVGO $63.89
  • Revenue Next Year
  • CVRX $25.87
  • EVGO $38.45
  • P/E Ratio
  • CVRX N/A
  • EVGO N/A
  • Revenue Growth
  • CVRX 30.53
  • EVGO 73.08
  • 52 Week Low
  • CVRX $6.40
  • EVGO $1.65
  • 52 Week High
  • CVRX $22.50
  • EVGO $9.07
  • Technical
  • Relative Strength Index (RSI)
  • CVRX 39.53
  • EVGO 34.13
  • Support Level
  • CVRX $14.07
  • EVGO $3.18
  • Resistance Level
  • CVRX $15.42
  • EVGO $3.20
  • Average True Range (ATR)
  • CVRX 0.88
  • EVGO 0.21
  • MACD
  • CVRX -0.23
  • EVGO 0.05
  • Stochastic Oscillator
  • CVRX 13.84
  • EVGO 26.09

About CVRX CVRx Inc.

CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.

About EVGO EVgo Inc.

EVgo owns and operates a public direct current fast-charging network in the us. Its network of charging stations provides electric vehicle charging infrastructure to consumers and businesses. The network is capable of charging all EV models and meets all charging standards currently available in the us. EVgo partners with national and regional chains of grocery stores, automotive original equipment manufacturers, hotels, shopping centers, gas stations, parking lot operators, local governments, and independent property owners to locate and deploy its EV charging infrastructure.

Share on Social Networks: